Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce its clinical strategy to ...
ProT-096 designed to address critical gaps in immune recovery for patients with refractory hematologic malignancies through a ...
A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...
Iopofosine I-131 achieved an overall response rate of 83.6% and a major response rate of 61.8% in patients with relapsed or ...
Colon, lung, and liver cancers are among the most prevalent and lethal cancers globally. Despite advancements in treatment, these cancers continue to pose significant challenges due to high mortality ...
2don MSN
Successfully treated acute myeloid leukemia patients may hold the key to new CAR T cell therapy
Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to ...
A noninvasive radiation treatment for ventricular tachycardia, known as STAR, has advanced into a pivotal randomized trial after encouraging early results in U.S. and European studies. The method uses ...
JNJ-4804 demonstrated highest rates of clinical and endoscopic outcomes compared to golimumab and guselkumab in patients with ulcerative colitis or Crohn's disease ...
Q1 2026 Earnings Call May 14, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...
US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s ...
Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV® study presented ...
Meet the Republican and Democratic candidates running for State Representative District 46 in Polk and Dallas counties.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results